TransMedics Group, Inc.TMDXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank89
5Y CAGR+116.1%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
+116.1%/yr
Long-term compound
Percentile
P89
Within normal range
vs 5Y Ago
47.1x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025295.14%
2024474.60%
202371.57%
2022-58.73%
20214.63%
20206.26%
2019-24.25%
2018-12.49%
20174.19%
20160.00%